NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

乳糖不耐症治療藥的全球市場分析:未來預測 (到2027年)

Global Lactose Intolerance Treatment Market Research Report-Forecast till 2027

出版商 Market Research Future 商品編碼 1008895
出版日期 內容資訊 英文 133 Pages
訂單完成後即時交付
價格
乳糖不耐症治療藥的全球市場分析:未來預測 (到2027年) Global Lactose Intolerance Treatment Market Research Report-Forecast till 2027
出版日期: 2021年02月01日內容資訊: 英文 133 Pages
簡介

全球乳糖不耐症治療藥的市場規模,預計在分析期間中 (2020年∼2027年) 以6.29%的年複合成長率成長,至2027年達到427億8332萬美元。各類型中的一次性乳糖不耐症,各治療法中的營養補充品,各形狀中的粉末成為最大的市場區隔。在各地區中,南北美洲是最大的市場,其次是歐洲,亞太地區也產生大幅度的市場成長。

本報告提供全球乳糖不耐症治療藥的市場相關分析,產業的基本結構和向心力,技術、法規環境,主要的推動及阻礙市場要素,各類型、各治療法、各形狀、各終端用戶、各地區的市場趨勢預測,主要企業的簡介、業績、策略等調查。

目錄

第1章 摘要整理

第2章 市場概要

第3章 分析方法

第4章 市場動態

  • 概要
  • 推動市場要素
    • 腸胃障礙的病例增加
    • 乳糖不耐症和相關併發症的興趣增加
    • 乳糖不耐症的盛行率上升
  • 阻礙市場要素
    • 補充品相關的副作用
  • 市場機會

第5章 市場要素分析

  • 價值鏈分析
    • 研究開發
    • 製造
    • 流通、銷售
    • 銷售後監測
  • 波特的五力分析
  • 投資機會

第6章 乳糖不耐症治療藥市場:各類型

  • 簡介
  • 一次性乳糖不耐症
  • 次發性乳糖不耐症
  • 先天性/發展性乳糖不耐症

第7章 乳糖不耐症治療藥市場:各治療法

  • 簡介
  • 營養補充品
  • 乳糖酵素酵素補充品
  • 益生菌

第8章 乳糖不耐症治療藥市場:各形狀

  • 簡介
  • 粉末
  • 液體
  • 錠劑、膠囊

第9章 全球乳糖不耐症各治療市場:各終端用戶

  • 簡介
  • 居家醫療
  • 醫院、診所

第10章 乳糖不耐症治療藥市場:各地區

  • 簡介
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 中國
    • 澳洲
    • 日本
    • 韓國
    • 其他
  • 中東、非洲
    • 中東
    • 非洲

第11章 競爭情形

  • 簡介
  • 企業佔有率分析

第12章 企業簡介

  • JOHNSON & JOHNSON SERVICES, INC.
  • NESTLE
  • ABBOTT
  • DEERLAND ENZYMES, INC.
  • RITTER PHARMACEUTICALS
  • GUARDIAN DRUG COMPANY
  • NOVOZYMES
  • CARGILL, INCORPORATED
  • ARLA FOODS
  • DEAN FOODS

第13章 附錄

目錄

Market Synopsis

As per the market research future analysis, the Global Lactose Intolerance Treatment Market is expected to register a CAGR of 6.29% during the assessment period of 2020 to 2027 to reach USD 42,783.32 Million by 2027. Lactose intolerance is an illness in which patient can not digest sugar in milk that causes diarrhoea, gas and bloating after eating or drinking dairy products.

The global lactose intolerance treatment market is expected to witness a healthy market growth during the review period. The lactose intolerance illness is of four main types of as primary lactase deficiency, secondary lactase deficiency, congenital lactase deficiency, and developmental lactase deficiency. According to the journal of health, population, and Nutrition published in 2017, the lactose intolerance incidences was higher in IBS-D patients as compared to healthy people.

Market Segmentation

Global Lactose Intolerance Treatment Market has been classified into Type, Treatment, Form, and End User.

Based on the type segment, Global Lactose Intolerance Treatment Market has been categorized into primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance. Primary lactose intolerance dominated the market in 2019. Primary lactose intolerance has a high prevalence rate as compared to others.

In terms of treatment the global market has been classified into food supplements, enzyme lactase supplements, probiotics. The food supplements segment is expected to dominate the market due to the largest market share in 2019. The growing adoption of Lactose-free products is fuelling the market growth of this segment.

By form segment, the market has been divided into powder, liquid, tablet. The powder segment held the largest market in 2019. Based on end user segment the global lactose intolerance treatment market has been categorized into homecare, hospitals and clinics, and others. The homecare segment is expected to lead the market during the forecast period owing to the largest share with a CAGR of 6.04% in 2019.

Regional Analysis

Geographically, the Global Lactose Intolerance Treatment Market has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to command the market during the study period owing to the largest market share in 2019. The region has further been categorized into North America and Latin America with North America is further divided into the US and Canada. The regional market growth is driven by the increasing prevalence of lactose intolerance and product innovation.

The Europe is expected to register second largest market of global lactose intolerance followed by Asia Pacific. The regional market is attributed to the existence of favourable government initiatives, research and development activities, and business expansions by major players.

The lactose intolerance treatment market in Asia-Pacific is anticipated to register the highest market growth expansion during the study period owing to rising healthcare expenditure, distribution of chilled dairy products in China, India, and Australia, and increasing population suffering from lactose intolerance.

Major Players

The Key Players in the Global Lactose Intolerance Treatment Market are Abbott (US)., Nestle (Switzerland), Cargill, Incorporated (US), Dean Foods (US), and Johnson & Johnson Services, Inc. (US).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 INTRODUCTION 14
  • 2.2 ASSUMPTIONS & LIMITATIONS 14
    • 2.2.1 ASSUMPTIONS 14
    • 2.2.2 LIMITATIONS 14
  • 2.3 MARKET STRUCTURE 14

3 RESEARCH METHODOLOGY

  • 3.1 RESEARCH PROCESS 15
  • 3.2 DATA MINING 15
  • 3.3 SECONDARY RESEARCH 16
  • 3.4 PRIMARY RESEARCH 17
  • 3.5 FORECASTING TECHNIQUES 19
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20
    • 3.6.1 BOTTOM-UP APPROACH 21
    • 3.6.2 TOP-DOWN APPROACH 21
    • 3.6.3 DATA TRIANGULATION 22
    • 3.6.4 VALIDATION 22

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION 23
  • 4.2 DRIVERS 23
    • 4.2.1 RISING CASES OF GASTROINTESTINAL DISORDERS 23
    • 4.2.2 INCREASING AWARENESS ABOUT LACTOSE INTOLERANCE AND RELATED COMPLICATIONS 24
    • 4.2.3 INCREASED PREVALENCE OF LACTOSE INTOLERANCE 24
  • 4.3 RESTRAINTS 25
    • 4.3.1 SIDE-EFFECTS ASSOCIATED WITH SUPPLEMENTS 25
  • 4.4 OPPORTUNITIES 25

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS 26
    • 5.1.1 R&D 26
    • 5.1.2 MANUFACTURING 26
    • 5.1.3 DISTRIBUTION & SALES 26
    • 5.1.4 POST-SALES MONITORING 26
  • 5.2 PORTER'S FIVE FORCES MODEL 27
    • 5.2.1 THREAT OF NEW ENTRANTS 27
    • 5.2.2 BARGAINING POWER OF SUPPLIERS 27
    • 5.2.3 THREAT OF SUBSTITUTES 28
    • 5.2.4 BARGAINING POWER OF BUYERS 28
    • 5.2.5 INTENSE RIVALRY 28
  • 5.3 INVESTMENT OPPORTUNITIES 28

6 LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE

  • 6.1 INTRODUCTION 29
  • 6.2 PRIMARY LACTOSE INTOLERANCE 31
  • 6.3 SECONDARY LACTOSE INTOLERANCE 31
  • 6.4 CONGENITAL/DEVELOPMENTAL LACTOSE INTOLERANCE 32

7 LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT

  • 7.1 INTRODUCTION 33
  • 7.2 FOOD SUPPLEMENTS 35
  • 7.3 ENZYME LACTASE SUPPLEMENTS 35
  • 7.4 PROBIOTICS 36

8 LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM

  • 8.1 INTRODUCTION 37
  • 8.2 POWDER 39
  • 8.3 LIQUID 39
  • 8.4 TABLETS & CAPSULES 40

9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET BY, END USER

  • 9.1 INTRODUCTION 41
  • 9.2 HOMECARE 43
  • 9.3 HOSPITALS & CLINICS 43

10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION

  • 10.1 INTRODUCTION 44
  • 10.2 AMERICAS 46
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.2.1 NORTH AMERICA 49
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.2.1.1 US 51
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.2.1.2 CANADA 53
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.2.2 LATIN AMERICA 55
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3 EUROPE 58
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.1 WESTERN EUROPE 61
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.1.1 GERMANY 64
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.1.2 FRANCE 66
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.1.3 UK 68
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.1.4 ITALY 70
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.1.5 SPAIN 72
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.1.6 REST OF WESTERN EUROPE 74
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.3.2 EASTERN EUROPE 76
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.4 ASIA-PACIFIC 78
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.4.1 CHINA 81
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.4.2 AUSTRALIA 83
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.4.3 JAPAN 85
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.4.4 INDIA 87
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.4.5 SOUTH KOREA 89
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.4.6 REST OF THE ASIA-PACIFIC 91
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.5 MIDDLE EAST & AFRICA 93
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.5.1 MIDDLE EAST 96
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
  • 10.5.2 AFRICA 98
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
    • LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION 100
  • 11.2 COMPANY SHARE ANALYSIS 100

12 COMPANY PROFILES

  • 12.1 JOHNSON & JOHNSON SERVICES, INC. 101
    • 12.1.1 COMPANY OVERVIEW 101
    • 12.1.2 FINANCIAL OVERVIEW 101
    • 12.1.3 PRODUCTS/SERVICES OFFERED 102
    • 12.1.4 KEY DEVELOPMENTS 102
    • 12.1.5 SWOT ANALYSIS 102
    • 12.1.6 KEY STRATEGIES 102
  • 12.2 NESTLE 103
    • 12.2.1 COMPANY OVERVIEW 103
    • 12.2.2 FINANCIAL OVERVIEW 103
    • 12.2.3 PRODUCTS/SERVICES OFFERED 104
    • 12.2.4 KEY DEVELOPMENTS 104
    • 12.2.5 SWOT ANALYSIS 104
    • 12.2.6 KEY STRATEGIES 105
  • 12.3 ABBOTT 106
    • 12.3.1 COMPANY OVERVIEW 106
    • 12.3.2 FINANCIAL OVERVIEW 106
    • 12.3.3 PRODUCTS/SERVICES OFFERED 106
    • 12.3.4 KEY DEVELOPMENTS 107
    • 12.3.5 SWOT ANALYSIS 107
    • 12.3.6 KEY STRATEGIES 107
  • 12.4 DEERLAND ENZYMES, INC. 108
    • 12.4.1 COMPANY OVERVIEW 108
    • 12.4.2 FINANCIAL OVERVIEW 108
    • 12.4.3 PRODUCTS/SERVICES OFFERED 108
    • 12.4.4 KEY DEVELOPMENTS 108
    • 12.4.5 SWOT ANALYSIS 109
    • 12.4.6 KEY STRATEGIES 109
  • 12.5 RITTER PHARMACEUTICALS 110
    • 12.5.1 COMPANY OVERVIEW 110
    • 12.5.2 FINANCIAL OVERVIEW 110
    • 12.5.3 PRODUCTS/SERVICES OFFERED 110
    • 12.5.4 KEY DEVELOPMENTS 110
    • 12.5.5 SWOT ANALYSIS 111
    • 12.5.6 KEY STRATEGIES 111
  • 12.6 GUARDIAN DRUG COMPANY 112
    • 12.6.1 COMPANY OVERVIEW 112
    • 12.6.2 FINANCIAL OVERVIEW 112
    • 12.6.3 PRODUCTS/SERVICES OFFERED 112
    • 12.6.4 KEY DEVELOPMENTS 112
    • 12.6.5 SWOT ANALYSIS 113
    • 12.6.6 KEY STRATEGIES 113
  • 12.7 NOVOZYMES 114
    • 12.7.1 COMPANY OVERVIEW 114
    • 12.7.2 FINANCIAL OVERVIEW 114
    • 12.7.3 PRODUCTS/SERVICES OFFERED 114
    • 12.7.4 KEY DEVELOPMENTS 115
    • 12.7.5 SWOT ANALYSIS 115
    • 12.7.6 KEY STRATEGIES 115
  • 12.8 CARGILL, INCORPORATED 116
    • 12.8.1 COMPANY OVERVIEW 116
    • 12.8.2 FINANCIAL OVERVIEW 116
    • 12.8.3 PRODUCTS/SERVICES OFFERED 116
    • 12.8.4 KEY DEVELOPMENTS 116
    • 12.8.5 SWOT ANALYSIS 117
    • 12.8.6 KEY STRATEGIES 117
  • 12.9 ARLA FOODS 118
    • 12.9.1 COMPANY OVERVIEW 118
    • 12.9.2 FINANCIAL OVERVIEW 118
    • 12.9.3 PRODUCTS/SERVICES OFFERED 119
    • 12.9.4 KEY DEVELOPMENTS 119
    • 12.9.5 SWOT ANALYSIS 119
    • 12.9.6 KEY STRATEGIES 120
  • 12.10 DEAN FOODS 121
    • 12.10.1 COMPANY OVERVIEW 121
    • 12.10.2 FINANCIAL OVERVIEW 121
    • 12.10.3 PRODUCTS/SERVICES OFFERED 121
    • 12.10.4 KEY DEVELOPMENTS 122
    • 12.10.5 SWOT ANALYSIS 122
    • 12.10.6 KEY STRATEGIES 122

13 APPENDIX

  • 13.1 REFERENCES 123
  • 13.2 RELATED REPORTS 123

LIST OF TABLES

  • TABLE 1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
  • TABLE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT, BY TYPE 2020-2027 (USD MILLION) 30
  • TABLE 3 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PRIMARY LACTOSE INTOLERANCE, BY REGION 2020 & 2027 (USD MILLION) 31
  • TABLE 4 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR SECONDARY LACTOSE INTOLERANCE, BY REGION 2020 & 2027 (USD MILLION) 31
  • TABLE 5 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR CONGENITAL/DEVELOPMENTAL LACTOSE INTOLERANCE, BY REGION 2020 & 2027 (USD MILLION) 32
  • TABLE 6 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 34
  • TABLE 7 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR FOOD SUPPLEMENT, BY REGION 2020 & 2027 (USD MILLION) 35
  • TABLE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR ENZYME LACTASE SUPPLEMENTS, BY REGION 2020 & 2027 (USD MILLION) 35
  • TABLE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PROBIOTICS, BY REGION 2020 & 2027 (USD MILLION) 36
  • TABLE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 38
  • TABLE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR POWDER, BY REGION 2020-2027 (USD MILLION) 39
  • TABLE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR LIQUID, BY REGION 2020-2027 (USD MILLION) 39
  • TABLE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR TABLETS/CAPSULES, BY REGION 2020-2027 (USD MILLION) 40
  • TABLE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 42
  • TABLE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOME CARE, BY REGION 2020-2027 (USD MILLION) 43
  • TABLE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOSPITAL & CLINICS, BY REGION 2020-2027 (USD MILLION) 43
  • TABLE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020-2027 (USD MILLION) 44
  • TABLE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020-2027 (USD MILLION) 46
  • TABLE 19 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 47
  • TABLE 20 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 47
  • TABLE 21 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 48
  • TABLE 22 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 48
  • TABLE 23 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020-2027 (USD MILLION) 49
  • TABLE 24 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 49
  • TABLE 25 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 50
  • TABLE 26 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 50
  • TABLE 27 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 51
  • TABLE 28 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 51
  • TABLE 29 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 52
  • TABLE 30 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 52
  • TABLE 31 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 53
  • TABLE 32 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 53
  • TABLE 33 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 54
  • TABLE 34 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 54
  • TABLE 35 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 55
  • TABLE 36 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 55
  • TABLE 37 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 56
  • TABLE 38 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 56
  • TABLE 39 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 57
  • TABLE 40 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020-2027 (USD MILLION) 58
  • TABLE 41 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 59
  • TABLE 42 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 59
  • TABLE 43 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 60
  • TABLE 44 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 60
  • TABLE 45 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020-2027 (USD MILLION) 61
  • TABLE 46 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 62
  • TABLE 47 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 62
  • TABLE 48 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 63
  • TABLE 49 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 63
  • TABLE 50 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 64
  • TABLE 51 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 64
  • TABLE 52 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 65
  • TABLE 53 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 65
  • TABLE 54 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 66
  • TABLE 55 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 66
  • TABLE 56 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 67
  • TABLE 57 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 67
  • TABLE 58 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 68
  • TABLE 59 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 68
  • TABLE 60 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 69
  • TABLE 61 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 69
  • TABLE 62 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 70
  • TABLE 63 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 70
  • TABLE 64 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 71
  • TABLE 65 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 71
  • TABLE 66 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 72
  • TABLE 67 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 72
  • TABLE 68 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 73
  • TABLE 69 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 73
  • TABLE 70 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 74
  • TABLE 71 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 74
  • TABLE 72 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 75
  • TABLE 73 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 75
  • TABLE 74 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 76
  • TABLE 75 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 76
  • TABLE 76 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 77
  • TABLE 77 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 77
  • TABLE 78 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020-2027 (USD MILLION) 78
  • TABLE 79 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 79
  • TABLE 80 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 79
  • TABLE 81 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 80
  • TABLE 82 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 80
  • TABLE 83 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 81
  • TABLE 84 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 81
  • TABLE 85 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 82
  • TABLE 86 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 82
  • TABLE 87 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 83
  • TABLE 88 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 83
  • TABLE 89 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 84
  • TABLE 90 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 84
  • TABLE 91 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 85
  • TABLE 92 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 85
  • TABLE 93 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 86
  • TABLE 94 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 86
  • TABLE 95 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 87
  • TABLE 96 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 87
  • TABLE 97 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 88
  • TABLE 98 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 88
  • TABLE 99 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 89
  • TABLE 100 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 89
  • TABLE 101 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 90
  • TABLE 102 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 90
  • TABLE 103 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 91
  • TABLE 104 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 91
  • TABLE 105 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 92
  • TABLE 106 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 92
  • TABLE 107 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020-2027 (USD MILLION) 93
  • TABLE 108 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 94
  • TABLE 109 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 94
  • TABLE 110 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 95
  • TABLE 111 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 95
  • TABLE 112 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 96
  • TABLE 113 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 96
  • TABLE 114 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 97
  • TABLE 115 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 97
  • TABLE 116 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020-2027 (USD MILLION) 98
  • TABLE 117 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020-2027 (USD MILLION) 98
  • TABLE 118 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 99
  • TABLE 119 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 99

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 13
  • FIGURE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET: MARKET STRUCTURE 14
  • FIGURE 3 PRIMARY RESPONDENT'S BREAKDOWN 18
  • FIGURE 4 BOTTOM-UP AND TOP-DOWN APPROACH 20
  • FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 23
  • FIGURE 6 VALUE CHAIN: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 26
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET 27
  • FIGURE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020 (%) 29
  • FIGURE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2020 & 2027 (USD MILLION) 30
  • FIGURE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020 (%) 33
  • FIGURE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2020 & 2027 (USD MILLION) 34
  • FIGURE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020 (%) 37
  • FIGURE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2020-2027 (USD MILLION) 38
  • FIGURE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020 (%) 41
  • FIGURE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2020-2027 (USD MILLION) 42
  • FIGURE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION2020-2027 (USD MILLION) 45
  • FIGURE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 45
  • FIGURE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 46
  • FIGURE 19 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020 (%) 49
  • FIGURE 20 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 58
  • FIGURE 21 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020 (%) 61
  • FIGURE 22 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2020 (%) 78
  • FIGURE 23 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2020 (%) 93
  • FIGURE 24 GLOBAL LACTOSE INTOLERANCE TREATMENT MAJOR PLAYERS MARKET SHARE ANALYSIS, 2020 (%) 100